Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sacubitril/Valsartan”

129 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 129 results

Large-scale testing (Phase 3)Study completedNCT03552575
What this trial is testing

The Effects of Sacubitril/Valsartan Compared to Valsartan on LV Remodelling in Asymptomatic LV Systolic Dysfunction After MI

Who this might be right for
Heart Failure
NHS Greater Glasgow and Clyde 93
Not applicableNot Yet RecruitingNCT07157527
What this trial is testing

Impact of Sacubitril/Valsartan on LV Diastolic Function in HFrEF

Who this might be right for
Left Ventricular Diastolic Function
Assiut University 70
Not applicableUnknownNCT04092309
What this trial is testing

Effect of Angiotensin Converting Enzyme and Sacubitril Valsartan in Patients After Bone Marrow Transplantation

Who this might be right for
Hematopoietic Stem Cell TransplantationCardiotoxicity
University of Athens 90
Post-approval studies (Phase 4)Not Yet RecruitingNCT07417215
What this trial is testing

The Effect of Sacubitril and Valsartan on Heart Function in Chronic Hemodialysis Patients With HFpEF

Who this might be right for
Heart Failure With Preserved Ejection Fraction (HFPEF)HemodialysisSacubitril/Valsartan
University Clinical Hospital Mostar 60
Not applicableStudy completedNCT07527767
What this trial is testing

Secondary Use of PARALLEL-HF Data

Who this might be right for
Chronic Heart Failure and Reduced Ejection Fraction (HFrEF)
Novartis Pharmaceuticals 236
Post-approval studies (Phase 4)Study completedNCT02816736
What this trial is testing

EntrestoTM (LCZ696) In Advanced Heart Failure (LIFE Study)

Who this might be right for
Heart Failure
Duke University 365
Not applicableUnknownNCT05934071
What this trial is testing

Effects of the Sodium-glucose Cotransporter 2 Inhibitors+Sacubitril/Valsartan Therapy in Patients With HFrEF.

Who this might be right for
Heart FailureVentricular RemodelingVentricular Dysfunction
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 160
Not applicableStudy completedNCT05976230
What this trial is testing

Special Drug Use Surveillance of Entresto Tablets (Hypertension)

Who this might be right for
Hypertension
Novartis Pharmaceuticals 1,125
Post-approval studies (Phase 4)UnknownNCT04197050
What this trial is testing

Effect of Sacubitril/Valsartan on Reduced Right Ventricular Ejection Fraction in Patients With CTD

Who this might be right for
Myocardial InjuryConnective Tissue Diseases
RenJi Hospital 60
Large-scale testing (Phase 3)Study completedNCT03988634
What this trial is testing

Changes in NT-proBNP, Safety, and Tolerability in HFpEF Patients With a WHF Event (HFpEF Decompensation) Who Have Been Stabilized and Initiated at the Time of or Within 30 Days Post-decompensation (PARAGLIDE-HF)

Who this might be right for
Heart Failure With Preserved Ejection Fraction (HFpEF)
Novartis Pharmaceuticals 467
Post-approval studies (Phase 4)UnknownNCT04103554
What this trial is testing

Sacubitril/Valsartan in Left Ventricular Assist Device Recipients

Who this might be right for
Heart Failure
University of Zagreb 60
Not applicableActive Not RecruitingNCT07465679
What this trial is testing

A Real-world Study of Clinical Treatment Guidelines for Patients With Heart Failure With Reduced Ejection Fraction Treated With Sacubitril/Valsartan

Who this might be right for
Heart Failure With Reduced Ejection Fraction
Novartis Pharmaceuticals 500
Not applicableStudy completedNCT05848206
What this trial is testing

Impact of Formulary Coverage of Entresto (Sacubitril/Valsartan) on Prescription Abandonment/Rejection and Subsequent Treatment and Economic Outcomes in Chronic Heart Failure Patients in the U.S.

Who this might be right for
Chronic Heart Failure
Novartis Pharmaceuticals 251,831
Large-scale testing (Phase 3)Study completedNCT07023016
What this trial is testing

Comparative Assessment of Efficacy & Safety of Sacubitril/Valsartan Versus Ramipril in Patients With Renal Dysfunction Hospitalized With Acute Decompensated Heart Failure

Who this might be right for
Acute Decompensated Heart Failure (ADHF)Chronic Kidney Disease (CKD)
National Heart Institute, Egypt 515
Large-scale testing (Phase 3)Study completedNCT06149104
What this trial is testing

A Safety Study of Sacubitril/Valsartan in Japanese Pediatric Patients With Heart Failure Due to Systemic Left Ventricle Systolic Dysfunction Who Have Completed CLCZ696B2319E1 Study

Who this might be right for
Heart Failure
Novartis Pharmaceuticals 8
Large-scale testing (Phase 3)Study completedNCT03785405
What this trial is testing

Open-label Extension Study to Evaluate Long-term Safety of Sacubitril/Valsartan in Pediatric Patients With HF

Who this might be right for
Heart Failure
Novartis Pharmaceuticals 216
Post-approval studies (Phase 4)UnknownNCT05060588
What this trial is testing

Sacubitril/Valsartan Versus Valsartan for Hypertensive Patients With Acute Myocardial Infarction

Who this might be right for
Myocardial InfarctionHypertension
Qingdao Central Hospital 200
Large-scale testing (Phase 3)Study completedNCT03917459
What this trial is testing

COmparing arNi and Ace For Improving Erectile Dysfunction in mEN With reduCed Ejection Fraction Heart Failure

Who this might be right for
Heart FailureHeart Failure, SystolicErectile Dysfunction
Novartis Pharmaceuticals 27
Very early researchUnknownNCT03771729
What this trial is testing

Observation on the Effect of Sacubitril/Valsartan in Advanced Chronic Kidney Disease（CKD）Patients With Heart Failure

Who this might be right for
CKD
The Second Affiliated Hospital of Harbin Medical University 30
Post-approval studies (Phase 4)Study completedNCT03168568
What this trial is testing

Differential Vascular and Endocrine Effects of Valsartan/Sacubitril in Heart Failure With Reduced Ejection Fraction

Who this might be right for
Heart Failure
University of Zurich 79
Load More Results